Molecular signatures of high salt induced pathogenic T cells
Molecular signatures of high salt induced pathogenic T cells
批准号:
8679551
负责人:
Chuan Wu
金额:
$11.14万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2015-06-30
关键词:
Academic TrainingAddressAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAreaAutoimmune DiseasesAutoimmune ProcessAutoimmunityCell CommunicationCellsChronicColitisComputational BiologyCrohn&aposs diseaseCuesDNA-Binding ProteinsDataDevelopmentDietDietary FactorsDiseaseDisease modelDisease susceptibilityDrug TargetingEnvironmentEnvironmental PollutantsEpidemicEpithelialEquilibriumExperimental Autoimmune EncephalomyelitisExposure toFoodFoundationsGene Expression ProfilingGene PoolGene ProteinsGenerationsGenesGeneticGenomicsGlucocorticoidsGoalsHealthHomeostasisHumanImmune systemImmunologyIn VitroIncidenceInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineInjuryIntakeInterleukin-17Interleukin-6KnowledgeLaboratoriesLeadLearningLinkMaintenanceMediatingMessenger RNAModelingMolecularMolecular BiologyMolecular ProfilingMucositisMultiple SclerosisMusPathogenesisPhenotypePhosphotransferasesPlayRegulatory T-LymphocyteResearchResearch PersonnelRoleSerumSignal TransductionSingle Nucleotide PolymorphismSmokingSodiumSodium ChannelSodium ChlorideSusceptibility GeneT cell differentiationT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsTechnical ExpertiseTestingTherapeuticTherapeutic InterventionTissuesTrainingUlcerative Colitisautoreactive T cellcytokineepithelial Na+ channelexperiencegenome wide association studyhistone modificationhuman diseasein vivoinsightinterleukin-23microbiomenew technologynovelpreventprogramsreceptorreconstructionsalt intaketherapeutic targetuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our objective is to define molecular signals that lead to activation of the mucosal immune system leading to autoimmune intestinal inflammation. We believe that these signals will lead to identification of therapeutic targets and help understand the pathogenesis of several human diseases including Inflammatory Bowel Disease (IBD). Th17 cells are highly proinflammatory cells that are critical for different autoimmune diseases. We have developed a research program that is aimed to elucidate the balance between inflammatory Th17 cells and the anti-inflammatory, regulatory T cells, Tregs. Our observation is that the balance between Th17 and Tregs is essential for tissue homeostasis in the gut. Thus, to identify novel regulators with Th17 cells, we performed temporal gene expression profiling of Th17 cells during differentiation. We found a target - SGK1, a kinase that is highly expressed in both Th17 and Tregs and regulates sodium intake of a cell. We discovered that SGK1 is critical stabilizing the Th17 cell phenotype. We also showed that a modest increase in salt concentration induces SGK1 expression and enhances Th17 cell.
The goal of this proposal is to understand that the chronic high salt intake in western diets, on a
genetically susceptible background, may act as a trigger for developing IBD by inducing pathogenic Th17 cells and disarming protective Tregs via SGK1. Furthermore, such study will ultimately facilitate the identification of environment triggers for the development of pathogenic Th17 cells and autoimmune diseases. We will then 1) investigate whether SGK1 regulates the reciprocal differentiation of Foxp3+ Treg and Th17 cell; 2) test that high salt intake can influenc the IBD development via induction of pathogenic Th17 and disarming Tregs mediated by SGK1; 3) computationally reconstruct an unbiased, mechanistic network within T cells of the interactions between proteins and genes that mediate the effect of high salt. This will allow us to
identify potential key regulators and drug targets that may overlap with IBD-susceptibility genes, and to examine with targeted perturbation their roles in influencing Th17/Treg balance and development of IBD. We can then explore the potential therapeutic approaches for IBD and other autoimmune diseases.
My short-term goal is to learn more about IBD research and understand the underlying T cell intrinsic and environmental cues that induce autoimmune T cells are induced to mediate gut autoimmunity. My long-term goal is to develop into an independent investigator in an academic setting. My research program will focus on the identification of new factors which can regulate T cell subsets differentiation and triggers for T cell- mediated autoimmune disorders, with the ultimate goal of identifying novel targets for therapeutic interventions for these diseases.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.immuni.2015.01.019
发表时间:
2015-02-17
期刊:
Immunity
影响因子:
32.4
作者:
[Wu C, Chen Z, Kuchroo VK]
通讯作者:
Kuchroo VK
Molecular signatures of high salt induced pathogenic T cells
-
批准号:9131613
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:Chuan Wu
-
依托单位:
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
-
批准号:10702680
-
项目类别:
-
资助金额:$55.73万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
The role of Foxo1 for intestinal epithelial cells during mucosal immune response
-
批准号:10702653
-
项目类别:
-
资助金额:$41.8万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
IL-33 promotes serotonin release from enterochromaffin cells
-
批准号:10487139
-
项目类别:
-
资助金额:$41.16万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
The role of Foxo1 for intestinal epithelial cells during mucosal immune response
-
批准号:10486952
-
项目类别:
-
资助金额:$41.16万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
IL-33 promotes serotonin release from enterochromaffin cells
-
批准号:10702826
-
项目类别:
-
资助金额:$41.8万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
Inter- and intra-epithelial regulation for intestinal barrier integrity
-
批准号:10926306
-
项目类别:
-
资助金额:$36.07万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
-
批准号:10486983
-
项目类别:
-
资助金额:$54.88万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
T cell regulation for intestinal barrier function
-
批准号:10926331
-
项目类别:
-
资助金额:$48.09万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
Immune-neuron crosstalk regulates intestinal homeostasis
-
批准号:10926462
-
项目类别:
-
资助金额:$36.07万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
The role of Foxo1 for intestinal epithelial cells during mucosal immune response
-
批准号:10262436
-
项目类别:
-
资助金额:$54.37万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
-
批准号:10262467
-
项目类别:
-
资助金额:$54.37万
-
财政年份:--
-
负责人:Chuan Wu
-
依托单位:
海外基金